Published in Obesity and Diabetes Week, March 21st, 2005
HPB-84 has, the company says, been used in a type II diabetes setting that has shown only positive results. These results indicate the anticipated growth of the nutraceutical in a market of at least 18.2 million type II diabetics in the United States alone.
Distribution of HPB-84 is now available for consumer use through HEE Corp.
Wellness Centers of America will be the largest distributor as they franchise their company worldwide.
Wellness Centers of America is a new company. It was...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.